Etanercept is Effective and Halts Radiographic Progression in Rheumatoid Arthritis and Psoriatic Arthritis: Final Results from a German Non-interventional Study (PRERA)

Abstract Introduction Etanercept (ETN) has been shown to slow radiographic progression of rheumatoid arthritis (RA) and psoriatic arthritis (PsA) in clinical trials. This real-world, non-interventional study assessed radiographic progression in patients with RA or PsA treated with ETN for ≤ 36 month...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Siegfried Wassenberg, Rolf Rau, Thilo Klopsch, Anja Plenske, Jürgen Jobst, Pascal Klaus, Thomas Meng, Peter-Andreas Löschmann
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	Adis, Springer Healthcare 2022-10-01
Edice:	Rheumatology and Therapy
Témata:	Rheumatoid arthritis Psoriatic arthritis Radiographic progression Etanercept Noninterventional study
On-line přístup:	https://doi.org/10.1007/s40744-022-00491-4
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!